Know Cancer

or
forgot password
  • cancer clinical trials in cherry hill, NJ

  • Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Chronic Lymphocytic Leukemia
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Ctr for Cancer & Hem Disease
    Cherry Hill, New Jersey 08003
    Non-Small Cell Lung Cancer
    Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
    Research Center In
    Cherry Hill, New Jersey
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Pharmatech Oncology Study Site
    Cherry Hill, New Jersey 08003
    Diffuse Large B-Cell Lymphoma
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Metastatic Pancreatic Cancer
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Ovarian Cancer
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    The Center for Cancer & Hematologic Disease
    Cherry Hill, New Jersey 08003
    Breast Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Multiple Myeloma
    Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Non-Squamous Non-Small Cell Lung Cancer
    A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreated With Recurrent or Advanced Non-small Cell Lung Cancer (NSCLC)
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Carcinoma, Non-Small-Cell Lung
    A Study in Second Line Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Colorectal Cancer
    A Study in Patients With Rheumatoid Arthritis
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Rheumatoid Arthritis
    A Study in Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Non-Small-Cell Lung Carcinoma
    A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Stomach Cancer, Esophageal Cancer
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    The Center for Cancer and Hematologic Disease Dept. of the CCHD
    Cherry Hill, New Jersey 08003
    Non-small Cell Lung Cancer
    A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Metastatic Clear Cell Renal Cell Carcinoma
    Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
    University of Pennsylvania Health System
    Cherry Hill, New Jersey 08034
    Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Solid Tumors
    A Study of LY2228820 for Recurrent Ovarian Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    A Moderate to Severe Rheumatoid Arthritis Study
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Rheumatoid Arthritis
    A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Squamous Non Small Cell Lung Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Center for Cancer And Hematologic Disease
    Cherry Hill, New Jersey 08046
    Colorectal Cancer
    Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
    Center for Cancer And Hematologic Disease
    Cherry Hill, New Jersey 08046
    Pancreatic Cancer
    Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Carcinoma, Non-Small-Cell Lung
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Center for Cancer And Hematologic Disease
    Cherry Hill, New Jersey 08046
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
    The Center for Cancer & Hematologic Disease
    Cherry Hill, New Jersey 08003
    Prostate Cancer
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Lung Cancer, Non-small-cell Lung Carcinoma
    Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Non Small Cell Lung Cancer
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Center for Cancer And Hematologic Disease
    Cherry Hill, New Jersey 08046
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Non-small Cell Lung Cancer Registry
    Center For Cancer & Hematologic Disease
    Cherry Hill, New Jersey 08003
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Center for Cancer & Hematology Disease
    Cherry Hill, New Jersey 08003
    Multiple Myeloma
    An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Genital Neoplasms, Female, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Peritoneal Neoplasms
    Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Carcinoma, Non-Small Cell Lung
    Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Small Cell Lung Cancer
    OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
    The Center for Cancer & Hematological Disease
    Cherry Hill, New Jersey 08003
    Fallopian Tube Cancer, Peritoneal Neoplasms, Ovarian Cancer
    A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma
    Center for Cancer And Hematologic Disease
    Cherry Hill, New Jersey 08046
    Lymphoma, Non-Hodgkin's
    Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Breast Neoplasms
    An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Pancreatic Cancer
    A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-small Cell Lung Cancer
    The Center for Cancer and Hematologic Disease
    Cherry Hill, New Jersey 08003
    Tumors
    A Study of Tasisulam Versus Paclitaxel as Treatment for Metastatic Melanoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Melanoma
    A Study for Patients With Small-Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Small Cell Lung Cancer
    A Phase 1 Study in Patients With Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cherry Hill, New Jersey 08003
    Solid Tumors